title: [Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
abstract: In the present study the authors evaluated treatment efficiency and patient compliance of medium-term therapy with Picotamide, given in doses of 900 mg/die for the first 15 days, and 600 mg/die up to the completion of a three-month period, to 50 patients affected by vaso-occlusive arterial disease of the lower limbs. At follow-up visits the following controls have been carried out: CW Doppler sonography of the lower limbs, Maximum Walking Distance (M.W.D.), Red blood cell count, White blood cell count, Platelet count, Haemoglobin and Fibrinogen levels. At the end of the three-month therapy period the Ankle-Arm parameters remained unchanged.
authors.affiliation: Istituto di Clinica Medica, Università degli Studi di Perugia.
authors.forename: G
authors.initials: G
authors.lastname: Tazza
authors.forename: R
authors.initials: R
authors.lastname: Tazza
authors.forename: M
authors.initials: M
authors.lastname: Valentini
authors.forename: G
authors.initials: G
authors.lastname: Leoni
authors.forename: N
authors.initials: N
authors.lastname: Avenia
authors.forename: M
authors.initials: M
authors.lastname: Ragusa
mesh_terms: D000368:Aged; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D010795:Phthalic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D010795:Phthalic Acids; C011581:picotamide
vernacular_title: Picotamide: utilizzo nelle arteriopatie obliteranti croniche degli arti inferiori.